Description

Amgen Inc.: What Is The Recent Pipeline Development & Expected Product Launches?

Amgen’s third quarter 2024 financial results underscore the biopharmaceutical company’s robust position in the market, with notable performance in both its core markets and pipeline advancements. Generating $8.5 billion in revenue, marking a 23% increase compared to the prior-year period, the company witnessed strong sales across its portfolio, particularly from 10 of its products which showed double-digit growth.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!